Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma

Oncotarget

Volumn 8, Issue 2, 2017, Pages 2076-2082

  Joung, Je Gun ^a   Ha, Sang Yun ^a   Bae, Joon Seol ^a   Nam, Jae Yong ^a   Gwak, Geum Youn ^a   Lee, Hae Ock ^a   Son, Dae Soon ^a,b   Park, Cheol Keun ^a   Park, Woong Yang ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

Copy number variation; Dysplastic nodules; Hepatocellular carcinoma; Single nucleotide variation; Whole exome sequencing

Indexed keywords

ARTICLE; CASE REPORT; CONTROLLED STUDY; COPY NUMBER VARIATION; DYSPLASIA; DYSPLASTIC NODULE; GENE FREQUENCY; GENETIC VARIATION; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALIGNANT TRANSFORMATION; MUTATIONAL ANALYSIS; PHYLOGENY; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; WHOLE EXOME SEQUENCING; AGED; CELL TRANSFORMATION; DISEASE EXACERBATION; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; LIVER CIRRHOSIS; LIVER TUMOR; MALE; MIDDLE AGED; PATHOLOGY; PRECANCER;

AGED; CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DNA COPY NUMBER VARIATIONS; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECANCEROUS CONDITIONS;

EID: 85009823748     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.10502     Document Type: Article

References (29)

1. Verslype C, Rosmorduc O, Rougier P and Group EGW. Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012; 23:vii41-48
2. Sadek AG, Mitchell DG, Siegelman ES, Outwater EK, Matteucci T and Hann HW. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology. 1995; 195:753-756
3. Stauffer JK, Scarzello AJ, Jiang Q and Wiltrout RH. Chronic inflammation, immune escape, and oncogenesis in the liver: a unique neighborhood for novel intersections. Hepatology. 2012; 56:1567-1574
4. Hytiroglou P, Theise ND, Schwartz M, Mor E, Miller C and Thung SN. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology. 1995; 21:703-708
5. Party IW. Terminology of nodular hepatocellular lesions. Hepatology. 1996; 22:983-993
6. Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M and Hirohashi S. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology. 2003; 37:198-207
7. Shibata R, Mori T, Du W, Chuma M, Gotoh M, Shimazu M, Ueda M, Hirohashi S and Sakamoto M. Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis. Clin Cancer Res. 2006; 12:5363-5368
8. Nault JC, Calderaro J, Di Tommaso L, Balabaud C, Zafrani ES, Bioulac-Sage P, Roncalli M and Zucman-Rossi J. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis. Hepatology. 2014; 60:1983-1992
9. Um TH, Kim H, Oh BK, Kim MS, Kim KS, Jung G and Park YN. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virusrelated human multistep hepatocarcinogenesis. J Hepatol. 2011; 54:939-947
10. Meyerson M, Gabriel S and Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 2010; 11:685-696
11. Chen Y, Wang L, Xu H, Liu X and Zhao Y. Exome capture sequencing reveals new insights into hepatitis B virusinduced hepatocellular carcinoma at the early stage of tumorigenesis. Oncol Rep. 2013; 30:1906-1912
12. Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y, Lee NP, Lee WH, Ariyaratne PN, Tennakoon C, Mulawadi FH, Wong KF, Liu AM, Poon RT, Fan ST, Chan KL, et al. Genomewide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012; 44:765-769
13. Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R and Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011; 12:R41
14. Tao Y, Ruan J, Yeh SH, Lu X, Wang Y, Zhai W, Cai J, Ling S, Gong Q, Chong Z, Qu Z, Li Q, Liu J, Yang J, Zheng C, Zeng C, et al. Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A. 2011; 108:12042-12047
15. Tan IB, Malik S, Ramnarayanan K, McPherson JR, Ho DL, Suzuki Y, Ng SB, Yan S, Lim KH, Koh D, Hoe CM, Chan CY, Ten R, Goh BK, Chung AY, Tan J, et al. High-depth sequencing of over 750 genes supports linear progression of primary tumors and metastases in most patients with liverlimited metastatic colorectal cancer. Genome Biol. 2015; 16:32
16. Brannon AR, Vakiani E, Sylvester BE, Scott SN, McDermott G, Shah RH, Kania K, Viale A, Oschwald DM, Vacic V, Emde AK, Cercek A, Yaeger R, Kemeny NE, Saltz LB, Shia J, et al. Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions. Genome Biol. 2014; 15:454
17. Lee YH, Oh BK, Yoo JE, Yoon SM, Choi J, Kim KS and Park YN. Chromosomal instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in dysplastic nodules of hepatitis B virus-associated multistep hepatocarcinogenesis. Mod Pathol. 2009; 22:1121-1131
18. Lee JM, Wong CM and Ng IO. Hepatitis B virus-associated multistep hepatocarcinogenesis: a stepwise increase in allelic alterations. Cancer Res. 2008; 68:5988-5996
19. Sottoriva A, Kang H, Ma Z, Graham TA, Salomon MP, Zhao J, Marjoram P, Siegmund K, Press MF, Shibata D and Curtis C. A Big Bang model of human colorectal tumor growth. Nat Genet. 2015; 47:209-216
20. Raidl M, Pirker C, Schulte-Hermann R, Aubele M, Kandioler-Eckersberger D, Wrba F, Micksche M, Berger W and Grasl-Kraupp B. Multiple chromosomal abnormalities in human liver (pre)neoplasia. J Hepatol. 2004; 40:660-668
21. Astolfi A, Urbini M, Indio V, Nannini M, Genovese CG, Santini D, Saponara M, Mandrioli A, Ercolani G, Brandi G, Biasco G and Pantaleo MA. Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST). BMC Genomics. 2015; 16:892
22. Yost SE, Smith EN, Schwab RB, Bao L, Jung H, Wang X, Voest E, Pierce JP, Messer K, Parker BA, Harismendy O and Frazer KA. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens. Nucleic Acids Res. 2012; 40:e107
23. Totoki Y, Tatsuno K, Covington KR, Ueda H, Creighton CJ, Kato M, Tsuji S, Donehower LA, Slagle BL, Nakamura H, Yamamoto S, Shinbrot E, Hama N, Lehmkuhl M, Hosoda F, Arai Y, et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat Genet. 2014; 46:1267-1273
24. Li H and Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009; 25:1754-1760
25. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly M and DePristo MA. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20:1297-1303
26. Nam JY, Kim NK, Kim SC, Joung JG, Xi R, Lee S, Park PJ and Park WY. Evaluation of somatic copy number estimation tools for whole-exome sequencing data. Brief Bioinform. 2015
27. Magi A, Tattini L, Cifola I, D'Aurizio R, Benelli M, Mangano E, Battaglia C, Bonora E, Kurg A, Seri M, Magini P, Giusti B, Romeo G, Pippucci T, De Bellis G, Abbate R, et al. EXCAVATOR: detecting copy number variants from whole-exome sequencing data. Genome Biol. 2013; 14:R120
28. Lin D, Shkedy Z, Yekutieli D, Amaratunga D and Bijnens L. (2012). Modeling dose-response microarray data in early drug development experiments using R. Springer
29. Zhang J, Fujimoto J, Wedge DC, Song X, Seth S, Chow CW, Cao Y, Gumbs C, Gold KA, Kalhor N, Little L, Mahadeshwar H, Moran C, Protopopov A, Sun H, Tang J, et al. Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing. Science. 2014; 346:256-259